News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

“Breast Cancer Talk” Review of Data from the SABCS 2020 Virtual Meeting

EP. 1: Metastatic Hormone-Receptor Positive Breast Cancer

ByWilliam J. Gradishar, MD, Northwestern University,Priyanka Sharma, MD, University of Kansas Cancer Center,Pavani Chalasani, MD, University of Arizona Cancer Center

January 27th 2021

EP. 2: Metastatic Hormone Epidermal Growth Factor Receptor 2-Positive Breast Cancer

ByWilliam J. Gradishar, MD, Northwestern University,Priyanka Sharma, MD, University of Kansas Cancer Center,Pavani Chalasani, MD, University of Arizona Cancer Center

January 27th 2021

EP. 3: Metastatic Triple-Negative Breast Cancer

ByWilliam J. Gradishar, MD, Northwestern University,Priyanka Sharma, MD, University of Kansas Cancer Center,Pavani Chalasani, MD, University of Arizona Cancer Center

January 27th 2021

Trending on OncLive

FDA Approves Capivasertib Plus Abiraterone and Prednisone for PTEN-Deficient mHSPC

FDA Approves Adjuvant Belzutifan Plus Pembrolizumab in ccRCC

Data Support Luspatercept at Maximum-Approved Dose for Transfusion-Dependent Lower-Risk MDS

Subgroup Analyses Confirm Clinically Meaningful Revumenib Responses in AML Across Mutational Profiles

Dr Marvin-Peek on the Significance of Efficacy Data for Azacitidine/Ivosidenib/Venetoclax in IDH1-Mutated AML